Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000588034 | SCV000149242 | uncertain significance | not provided | 2024-08-14 | criteria provided, single submitter | clinical testing | Published functional studies are inconclusive: protein expression and protein binding comparable to wildtype, inconclusive cell cycle arrest activity, and reduced protein abundance and methylation (PMID: 9473234, 19141585, 21462282); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28866070, 9823374, 12461329, 9808520, 21462282, 19141585, 19360740, 9782052, 8841025, 26205736, 28767289, 11360201, 29533785, 16818274, 28765326, 18519632, 9751050, 27960642, 27756164, 12417040, 9473234, 9166859, 7718873, 35001868, 30038052) |
Labcorp Genetics |
RCV000229571 | SCV000283442 | likely benign | Familial melanoma | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000570355 | SCV000669175 | likely benign | Hereditary cancer-predisposing syndrome | 2019-01-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000570355 | SCV000689600 | benign | Hereditary cancer-predisposing syndrome | 2021-01-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000855587 | SCV000695338 | benign | not specified | 2021-12-17 | criteria provided, single submitter | clinical testing | Variant summary: CDKN2A c.298G>T (p.Ala100Ser) results in a conservative amino acid change located in the Ankyrin repeat-containing domain (IPR020683) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 9.7e-05 in 236362 control chromosomes, predominantly at a frequency of 0.0013 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 4-fold of the estimated maximal expected allele frequency for a pathogenic variant in CDKN2A causing Cutaneous Malignant Melanoma phenotype (0.0003), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.298G>T has been reported in the literature without strong evidence for causality (e.g. Yarbrough_1996, Gamieldien_1998, Klangby_1998, Yanagawa_2002, Agrawal_2009, Patel_2017, Shindo_2017, McWilliams_2018). These reports do not provide unequivocal conclusions about association of the variant with Cutaneous Malignant Melanoma. Experimental evidence indicated that the variant does not significantly affect protein function (Lindstrom_2001, Miller_2011, Ng_2018). Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant with as benign (n=2), likely benign (n=2) and VUS (n=2). Based on the evidence outlined above, the variant was classified as benign. |
Mendelics | RCV000988151 | SCV001137764 | likely benign | Melanoma-pancreatic cancer syndrome | 2024-04-09 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000855587 | SCV001470488 | benign | not specified | 2020-07-30 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000570355 | SCV002534326 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-10 | criteria provided, single submitter | curation |